These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 23861325
1. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions. Liao ND, Chiang TA, Lee WY. Cancer Cytopathol; 2013 Dec; 121(12):695-702. PubMed ID: 23861325 [Abstract] [Full Text] [Related]
2. Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry. Liao ND, Lee WY. Cancer Cytopathol; 2012 Aug 25; 120(4):269-75. PubMed ID: 22367930 [Abstract] [Full Text] [Related]
3. Diagnostic value of metabolic phenotypes in malignant pleural effusions: expression of GLUT1 and CAIX by immunocytochemistry. Liao ND, Shieh JM, Lee WY. Cancer Cytopathol; 2011 Oct 25; 119(5):346-53. PubMed ID: 21442770 [Abstract] [Full Text] [Related]
4. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Burstein DE, Reder I, Weiser K, Tong T, Pritsker A, Haber RS. Mod Pathol; 1998 Apr 25; 11(4):392-6. PubMed ID: 9578091 [Abstract] [Full Text] [Related]
5. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions. Duysinx BC, Corhay JL, Hubin L, Nguyen D, Henket M, Louis R. Respir Med; 2008 Dec 25; 102(12):1708-14. PubMed ID: 18760578 [Abstract] [Full Text] [Related]
6. Immunocytochemistry and ELISA quantitation of mucin for diagnosis of malignant pleural effusions. Yang PC, Luh KT, Kuo SH, Wu CW. Am Rev Respir Dis; 1992 Dec 25; 146(6):1571-5. PubMed ID: 1456577 [Abstract] [Full Text] [Related]
7. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures. Elia S, Massoud R, Guggino G, Cristino B, Cortese C, De Massimi AR, Zenobi R. Eur J Cardiothorac Surg; 2008 Apr 25; 33(4):723-7. PubMed ID: 18261916 [Abstract] [Full Text] [Related]
8. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions. Zhou WB, Bai M, Jin Y. Int J Tuberc Lung Dis; 2009 Mar 25; 13(3):381-6. PubMed ID: 19275801 [Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications. Fiorelli A, Vicidomini G, Di Domenico M, Napolitano F, Messina G, Morgillo F, Ciardiello F, Santini M. Interact Cardiovasc Thorac Surg; 2011 Mar 25; 12(3):420-4. PubMed ID: 21172937 [Abstract] [Full Text] [Related]
10. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion. Görgün D, Seçik F, Midilli K, Akkaya V, Yıldız P. Respir Med; 2013 Aug 25; 107(8):1260-5. PubMed ID: 23791464 [Abstract] [Full Text] [Related]
11. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J. Ann Thorac Surg; 2008 Jan 25; 85(1):265-72; discussion 272. PubMed ID: 18154821 [Abstract] [Full Text] [Related]
12. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination. Lee WY. Cytopathology; 2005 Oct 25; 16(5):227-32. PubMed ID: 16181308 [Abstract] [Full Text] [Related]
13. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions. Gaspar MJ, De Miguel J, García Díaz JD, Díez M. Anticancer Res; 2008 Oct 25; 28(5B):2947-52. PubMed ID: 19031938 [Abstract] [Full Text] [Related]
14. The diagnostic significance of the detection of cytokeratin 19 mRNA by quantitative RT-PCR in benign and malignant pleural effusions. Xu F, Chen J, Shen HH, Wang XD, Shan J. J Zhejiang Univ Sci; 2004 Oct 25; 5(10):1286-9. PubMed ID: 15362202 [Abstract] [Full Text] [Related]
15. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions. Afify A, Lynne LC, Howell L. Diagn Cytopathol; 2007 Feb 25; 35(2):105-10. PubMed ID: 17230576 [Abstract] [Full Text] [Related]
16. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients. Villena V, López-Encuentra A, Echave-Sustaeta J, Martín-Escribano P, Ortuño-de-Solo B, Estenoz-Alfaro J. Cancer; 1996 Aug 15; 78(4):736-40. PubMed ID: 8756365 [Abstract] [Full Text] [Related]
17. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Benlloch S, Galbis-Caravajal JM, Martín C, Sanchez-Paya J, Rodríguez-Paniagua JM, Romero S, Mafe JJ, Massutí B. Cancer; 2006 Oct 15; 107(8):1859-65. PubMed ID: 16983705 [Abstract] [Full Text] [Related]
18. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema. Bishara J, Goldberg E, Ashkenazi S, Yuhas Y, Samra Z, Saute M, Shaked H. Ann Thorac Surg; 2009 Jan 15; 87(1):251-4. PubMed ID: 19101307 [Abstract] [Full Text] [Related]
19. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion]. Wei F, Wei Y, Li LF, Li GL, Wang GJ. Zhonghua Zhong Liu Za Zhi; 2017 Jul 23; 39(7):524-527. PubMed ID: 28728299 [Abstract] [Full Text] [Related]
20. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis. Tian P, Shen Y, Feng M, Zhu J, Song H, Wan C, Chen L, Wen F. Postgrad Med; 2015 Jun 23; 127(5):529-34. PubMed ID: 25979108 [Abstract] [Full Text] [Related] Page: [Next] [New Search]